Andrea T. Nguyen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Andrea T. Nguyen has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Stephanie Gras
GenomEast platform, IGBMC, 67404 Illkirch, France
3 shared publications - Emma J. Grant
Infection and Immunity Program, La Trobe Institute for Molecular Science (LIMS) La Trobe University Bundoora VIC Australia
2 shared publications - Adrian Miller
Jirrbal Aboriginal Corporation, Ravenshoe, QLD 4888, Australia
1 shared publication - Allen C. Cheng
Monash University
1 shared publication - Andrew G. Brooks
Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC 3010, Australia
1 shared publication - Anthony Wayne Purcell
Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Melbourne, VIC 3800, Australia
1 shared publication
Latest Publications
- Open Access
- 23 December 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (1) , 73
The Many Faces of CD4+ T Cells: Immunological and Structural Characteristics
As a major arm of the cellular immune response, CD4+ T cells are important in the control and clearance of infections. Primarily described as helpers, CD4+ T cells play an integral role in the development and activation of B cells and CD8+ T cells. CD4+ T cells are incredibly heterogeneous, and can be divided into six main lineages based on distinct profiles, namely T helper 1, 2, 17 and 22 (Th1, Th2, Th17, Th22), regulatory T cells (Treg) and T follicular helper cells (Tfh). Recent advances in structural biology have allowed for a detailed characterisation of the molecular mechanisms that drive CD4+ T cell recognition. In this review, we discuss the defining features of the main human CD4+ T cell lineages and their role in immunity, as well as their structural characteristics underlying their detection of pathogens.
- 23 December 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (1) , 73
Open AccessThe Many Faces of CD4+ T Cells: Immunological and Structural Characteristics
As a major arm of the cellular immune response, CD4+ T cells are important in the control and clearance of infections. Primarily described as helpers, CD4+ T cells play an integral role in the development and activation of B cells and CD8+ T cells. CD4+ T cells are incredibly heterogeneous, and can be divided into six main lineages based on distinct profiles, namely T helper 1, 2, 17 and 22 (Th1, Th2, Th17, Th22), regulatory T cells (Treg) and T follicular helper cells (Tfh). Recent advances in structural biology have allowed for a detailed characterisation of the molecular mechanisms that drive CD4+ T cell recognition. In this review, we discuss the defining features of the main human CD4+ T cell lineages and their role in immunity, as well as their structural characteristics underlying their detection of pathogens.
- Open Access
- 23 December 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (1) , 68
TCR Recognition of Peptide–MHC-I: Rule Makers and Breakers
T cells are a critical part of the adaptive immune system that are able to distinguish between healthy and unhealthy cells. Upon recognition of protein fragments (peptides), activated T cells will contribute to the immune response and help clear infection. The major histocompatibility complex (MHC) molecules, or human leukocyte antigens (HLA) in humans, bind these peptides to present them to T cells that recognise them with their surface T cell receptors (TCR). This recognition event is the first step that leads to T cell activation, and in turn can dictate disease outcomes. The visualisation of TCR interaction with pMHC using structural biology has been crucial in understanding this key event, unravelling the parameters that drive this interaction and their impact on the immune response. The last five years has been the most productive within the field, wherein half of current unique TCR–pMHC-I structures to date were determined within this time. Here, we review the new insights learned from these recent TCR–pMHC-I structures and their impact on T cell activation.
- 23 December 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (1) , 68
Open AccessTCR Recognition of Peptide–MHC-I: Rule Makers and Breakers
T cells are a critical part of the adaptive immune system that are able to distinguish between healthy and unhealthy cells. Upon recognition of protein fragments (peptides), activated T cells will contribute to the immune response and help clear infection. The major histocompatibility complex (MHC) molecules, or human leukocyte antigens (HLA) in humans, bind these peptides to present them to T cells that recognise them with their surface T cell receptors (TCR). This recognition event is the first step that leads to T cell activation, and in turn can dictate disease outcomes. The visualisation of TCR interaction with pMHC using structural biology has been crucial in understanding this key event, unravelling the parameters that drive this interaction and their impact on the immune response. The last five years has been the most productive within the field, wherein half of current unique TCR–pMHC-I structures to date were determined within this time. Here, we review the new insights learned from these recent TCR–pMHC-I structures and their impact on T cell activation.
- Open Access
CD8 + T-cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorph
Indigenous people worldwide are at high-risk of developing severe influenza disease. HLA-A*24:02 allele, highly prevalent in Indigenous populations, is associated with influenza-induced mortality, although the basis for this association is unclear. We defined CD8 + T-cell immune landscapes against influenza A (IAV) and B (IBV) viruses in HLA-A*24:02-expressing Indigenous and non-Indigenous individuals, human tissues, influenza-infected patients and HLA-A*24:02-transgenic mice. We identified immunodominant protective CD8 + T-cell epitopes, one towards IAV and six towards IBV, with A24/PB2 550-558 -specific CD8 + T-cells cells being cross-reactive between IAV and IBV. Memory CD8 + T-cells towards these specificities were present in blood (CD27 + CD45RA - phenotype) and tissues (CD103 + CD69 + phenotype) of healthy subjects, and effector CD27 - CD45RA - PD-1 + CD38 + CD8 + T-cells in IAV/IBV patients. Our data present the first evidence of influenza-specific CD8 + T-cell responses in Indigenous Australians, and advocate for T-cell-mediated vaccines that target and boost the breadth of IAV/IBV-specific CD8 + T-cells to protect high-risk HLA-A*24:02-expressing Indigenous and non-Indigenous populations from severe influenza disease. One Sentence Summary: Influenza-specific CD8 + T-cell specificities restricted by HLA-A*24:02.
Open AccessCD8 + T-cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorph
Indigenous people worldwide are at high-risk of developing severe influenza disease. HLA-A*24:02 allele, highly prevalent in Indigenous populations, is associated with influenza-induced mortality, although the basis for this association is unclear. We defined CD8 + T-cell immune landscapes against influenza A (IAV) and B (IBV) viruses in HLA-A*24:02-expressing Indigenous and non-Indigenous individuals, human tissues, influenza-infected patients and HLA-A*24:02-transgenic mice. We identified immunodominant protective CD8 + T-cell epitopes, one towards IAV and six towards IBV, with A24/PB2 550-558 -specific CD8 + T-cells cells being cross-reactive between IAV and IBV. Memory CD8 + T-cells towards these specificities were present in blood (CD27 + CD45RA - phenotype) and tissues (CD103 + CD69 + phenotype) of healthy subjects, and effector CD27 - CD45RA - PD-1 + CD38 + CD8 + T-cells in IAV/IBV patients. Our data present the first evidence of influenza-specific CD8 + T-cell responses in Indigenous Australians, and advocate for T-cell-mediated vaccines that target and boost the breadth of IAV/IBV-specific CD8 + T-cells to protect high-risk HLA-A*24:02-expressing Indigenous and non-Indigenous populations from severe influenza disease. One Sentence Summary: Influenza-specific CD8 + T-cell specificities restricted by HLA-A*24:02.